By integrating classical risk factors with organ damage markers (microalbuminuria, reduced eGFR), functional cardiac indices (diastolic dysfunction, GLS, LA strain), and biochemical markers of oxidative stress and endothelial dysfunction (homocysteine, PON1), PulsIn identifies patients whose “true” risk is higher than what standard scores alone would indicate. The gene discussed is PON1; the disease is endothelial dysfunction.